Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan:35 Suppl 1:55-61.
doi: 10.1007/BF03319103.

Geriatric conditions and the risk of adverse drug reactions in older adults: a review

Affiliations
Review

Geriatric conditions and the risk of adverse drug reactions in older adults: a review

Fabrizia Lattanzio et al. Drug Saf. 2012 Jan.

Abstract

While polypathology and polypharmacy are well known risk factors for adverse drug reactions (ADRs), the association between geriatric conditions (GCs), i.e. a set of clinical and functional problems partly constitutive of and partly related to frailty, and ADRs is suspected but has not been fully elucidated. Several studies have assessed the relationship between single GCs and ADRs, but only a few studies have systematically evaluated the relationship between the whole spectrum of GCs and ADRs. The mechanism by which select GCs increase the risk of developing ADRs during a hospital stay might simply reflect a sort of general predictability of physical disability with respect to adverse outcomes. However, GCs pertaining to the physical dimension of frailty are generally associated with relevant changes in pharmacokinetics and pharmacodynamics of select drugs. While current evidence could not be considered either unequivocal or conclusive, select GCs, e.g. a history of falls and loss of independence in the activities of daily living, seem to define a condition of particular vulnerability of elderly patients to ADRs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Am Geriatr Soc. 2011 Apr;59(4):615-21 - PubMed
    1. Curr Med Chem. 2010;17(6):571-84 - PubMed
    1. JAMA. 1998 Feb 25;279(8):585-92 - PubMed
    1. Curr Drug Metab. 2011 Sep;12(7):621-34 - PubMed
    1. Arch Intern Med. 2010 Jul 12;170(13):1142-8 - PubMed

LinkOut - more resources